Short-acting inhaled bronchodilators for cystic fibrosis-Reference-Cited by-同舟云学术

Short-acting inhaled bronchodilators for cystic fibrosis

Published:2022-06-24 Issue:6 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Smith Sherie¹,Rowbotham Nicola J¹,Edwards Christopher T²

Affiliation:

1. Academic Unit of Lifespan and Population Health, School of Medicine; University of Nottingham; Nottingham UK

2. Leeds Regional Paediatric Respiratory & Cystic Fibrosis Centre; A Floor, Clarendon Wing, Leeds Children's Hospital; Leeds UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference88 articles.

1. The effects of inhaled B2 agonists on maximal exercise in patients with cystic fibrosis ;Dodd;American Journal of Respiratory and Critical Care Medicine,2001

2. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis;Dodd;Journal of Cystic Fibrosis,2005

3. Duncan FR Penketh AR Hodson ME Batten JC The use of bronchodilators as an adjunct to physiotherapy, in adults with cystic fibrosis 11th European Cystic Fibrosis Conference, 1982; Brussels 1982 48

4. A controlled trial of long-term bronchodilator therapy in cystic fibrosis;Eggleston;Chest,1991

5. Long-term inhaled bronchodilator therapy in cystic fibrosis. Comment on Eggleston PA, Rosenstein BJ, Stackhouse CM, Mellits ED, Baumgardner RA. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest 1991;99(5):1088-92;Orenstein;Chest,1991

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchodilator response assessment through impulse oscillometry system and spirometry in children and adolescents with cystic fibrosis;Revista Paulista de Pediatria;2024

2. Predicting the tolerability of inhalation therapy as a stage of a personalized approach in the treatment of children with cystic fibrosis;CHILD`S HEALTH;2023-06-03